EDGAR Filing Documents for 0001213900-17-002475

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001213900-17-002475

Filing Date

2017-03-16

Accepted

2017-03-16 16:50:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	fs32017_actiniumpharma.htm	S-3	925092
2	FORM OF UNDERWRITING AGREEMENT	fs32017ex1ii_actiniumpharma.htm	EX-1.2	299796
3	OPINION OF THE MATT LAW FIRM, PLLC	fs32017ex5i_actiniumpharma.htm	EX-5.1	25618
4	CONSENT OF GBH CPAS, PC	fs32017ex23i_actiniumpharma.htm	EX-23.1	1998
5	GRAPHIC	image_003.jpg	GRAPHIC	11393
6	GRAPHIC	ex5i_001.jpg	GRAPHIC	21925
	Complete submission text file	0001213900-17-002475.txt		1299719

Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016

Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875

Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)